GRM5 and depressive disorder: Indeed, pharmacological blockade of mPFC-mGluR5 in our chronic neuropathic pain model animal was sufficient to relieve the both of the nerve injury-induced pain and the depression symptoms which are experimentally assessed by paw withdrawal threshold in von Frey test and immobility time in FST respectively.